The Bone Graft Substitutes market is anticipated to witness significant growth, expanding from USD 3.1 billion in 2022 to USD 5.6 billion by 2032, at a CAGR of 6.2% during the forecast period from 2022 to 2032. The market growth is driven by several key factors, including the increasing prevalence of orthopedic diso.
Analysts Offer Insights on Healthcare Companies: Cooper Co (COO), Vertex Pharmaceuticals (VRTX) and Guardant Health (GH) businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.
Integra LifeSciences (NASDAQ:IART – Free Report) had its target price lifted by Citigroup from $24.00 to $28.00 in a research report report published on Wednesday morning, Benzinga reports. Citigroup currently has a neutral rating on the life sciences company’s stock. IART has been the topic of several other reports. StockNews.com cut Integra LifeSciences from a […]
Integra LifeSciences (NASDAQ:IART – Free Report) had its price objective lifted by Citigroup from $24.00 to $28.00 in a report released on Wednesday morning, Benzinga reports. They currently have a neutral rating on the life sciences company’s stock. A number of other brokerages have also recently commented on IART. StockNews.com cut Integra LifeSciences from a […]